Tibetan medicine external treatment gamma therapy standardization method for gouty arthritis
By standardizing the external treatment method of Tibetan medicine, using Xiuqiong Enbao powder and Kacha medicine powder mixed with barley wine to apply as a plaster, the problem of unstable treatment effect of gouty arthritis has been solved, achieving safe and effective relief of joint inflammation and reduction of inflammatory factors, and adapting to the personalized treatment needs of different patients.
Patent Information
- Application Number
- CN202511592174.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-03
- Publication Date
- 2026-01-27
AI Technical Summary
The lack of unified technical standards in existing Tibetan medicine external treatments leads to unstable treatment effects for gouty arthritis, making it difficult to promote. Furthermore, traditional methods suffer from low patient compliance and side effects.
This invention provides a standardized method for the external treatment of gouty arthritis using Tibetan medicine, including standardized diagnosis, drug compatibility, preparation and application. The method involves mixing Xiuqiong Enbao powder and Kacha medicine powder with barley wine to make a paste, which is then applied to the affected area. The efficacy is evaluated through a multi-day treatment course and objective indicators.
It achieves stable and repeatable therapeutic effects, significantly relieves symptoms of joint redness, swelling, heat and pain, reduces serum inflammatory factor levels, avoids systemic side effects, has strong adaptability, and is compatible with comprehensive treatment using both internal and external therapies.
Smart Images

Figure CN121401331A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of Tibetan medicine technology, and in particular relates to a standardized method for the external treatment of gouty arthritis using Tibetan medicine, specifically the Gaji therapy. Background Technology
[0002] Gouty arthritis is an inflammatory joint disease caused by hyperuricemia. It is characterized by the deposition of urate crystals in the joints and surrounding tissues, leading to acute or chronic inflammatory reactions. Clinical manifestations include sudden onset of severe joint pain, redness, swelling, heat, and functional impairment.
[0003] Currently, Western medicine treatments mainly use nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and glucocorticoids. These drugs can control symptoms, but long-term use can easily cause adverse reactions such as gastrointestinal, liver, and kidney damage. Traditional Tibetan medicine therapies, such as bloodletting, are effective, but they are invasive procedures with low patient acceptance and require high skill levels, making them difficult to promote.
[0004] Tibetan herbal poultice therapy (Gyaji therapy) is one of the important external treatment methods in Tibetan medicine, with advantages such as being green, non-invasive, and having high patient compliance. However, traditional Gyaji therapy relies heavily on the individual experience of physicians for drug compatibility, processing techniques, application procedures, and treatment course evaluation, lacking unified technical standards. This non-standardized state leads to unstable therapeutic effects, making it difficult to conduct large-scale clinical validation, quality control, and widespread application.
[0005] Therefore, there is an urgent need in the existing technology for a standardized Tibetan medicine external treatment program that is effective, easy to operate, reproducible, and easy to promote, in order to solve the treatment problem of gouty arthritis. Summary of the Invention
[0006] The purpose of this invention is to overcome the shortcomings of existing technologies and provide a standardized method for the external treatment of gouty arthritis using Tibetan medicine. This method establishes a complete, unified, and repeatable technical standard through standardized diagnostic, drug compatibility, preparation, and application procedures, ensuring the stable efficacy and safety of the treatment.
[0007] To solve the above-mentioned technical problems, the present invention is achieved through the following technical solution: This invention relates to a standardized method for the external treatment of gouty arthritis using Tibetan medicine, characterized by the following steps: S1. Diagnosis and Inclusion: Based on Tibetan medicine theory, the patient was diagnosed with gouty arthritis. S2. Preparation of ointment: Mix the Tibetan medicine composition containing Xiuqiong Enbao powder and Kacha medicine powder with highland barley wine to make an ointment for external use; S3. Applying the ointment to the affected joint: Apply the ointment to the affected joint of the patient and fix it in place. Apply the ointment 1-2 times a day. S4. Treatment Course and Evaluation: A treatment course consists of several days, and the efficacy is evaluated before and after treatment.
[0008] Preferably, in S1, the Tibetan medicine diagnosis needs to meet the following conditions: the pulse is short and tight, and the urine shows signs of heat and has a burnt horn smell.
[0009] Preferably, in step S2, the alcohol volume fraction of the highland barley wine is 40%–50%, and its addition amount is 1.0–1.5 times the total mass of the carding powder; and / or, the carding powder is pulverized to 80-120 mesh.
[0010] Preferably, the raw materials and their weight ratios of the Tibetan medicine composition in S2 are as follows: Xiuqiong Enbao powder: 200-300 parts; Kacha medicine powder: 150-200 parts; the Kacha medicine powder is composed of Bangzijuni powder: 25-35 parts, sickle-shaped thorn bean: 35-45 parts, cassia seed: 15-25 parts, yellow okra seed: 15-25 parts, amber: 15-25 parts, catechu: 15-25 parts, and iron bar hammer: 15-25 parts; and the iron bar hammer is a processed medicinal slice that has undergone detoxification treatment.
[0011] More preferably, the raw materials and their weight ratios of the Tibetan medicine composition in S2 are as follows: Xiuqiong Enbao powder: 250 parts; Kacha medicine powder: 170 parts; the Kacha medicine powder is composed of Bangzijuni powder: 28-32 parts, sickle-shaped thorn bean: 38-42 parts, cassia seed: 18-22 parts, yellow sunflower seed: 18-22 parts, amber: 18-22 parts, catechu: 18-22 parts, and iron bar hammer: 18-22 parts.
[0012] Furthermore, in S2, the proportions of the cardiotonic powder components can be adjusted according to the severity of the patient's symptoms: when the joint swelling score is ≥4, the weight of the falciformis is increased to 40-45 parts; when the joint pain score is ≥4, the weight of the iron bar is increased to 20-25 parts.
[0013] Preferably, in step S3, plastic wrap is used for fixation, the application time is 45 minutes to 1 hour, and the ointment thickness is 0.3-0.5 cm.
[0014] Preferably, during the application of patch therapy in S3, oral Tibetan medicine can be used as an adjunct therapy, wherein the oral Tibetan medicine includes at least one of Renqing Mangjue Pill, Eighteen Flavor Frankincense Pill, and Twenty-Five Flavor Donkey Blood Powder.
[0015] Preferably, in S4, a treatment course lasts 7 to 14 days; the efficacy is assessed by changes in serum inflammatory factor levels before and after treatment, including interleukin-6 (IL-6), procalcitonin (PCT), and high-sensitivity C-reactive protein (hs-CRP).
[0016] The present invention has the following beneficial effects: Standardization and repeatability: This invention is the first to transform Tibetan medicine's Gyaji therapy from a traditional model that relies on personal experience into a complete standardized scheme that includes quantitative diagnostic standards, precise drug ratios, unified operating parameters, and an objective efficacy evaluation system, ensuring the stability and repeatability of the therapeutic effect.
[0017] Significant therapeutic effect and safety: Through specific drug combinations and local application, it can quickly relieve the main symptoms of joint redness, swelling, heat, and pain, and significantly reduce the levels of key inflammatory factors such as serum IL-6, PCT, and hs-CRP. At the same time, the external treatment method avoids the systemic side effects of oral medications, and the iron rod used has undergone detoxification treatment, ensuring high safety.
[0018] Personalized and comprehensive treatment: This invention provides a formula ratio that can be dynamically adjusted according to the severity of symptoms, embodying the essence of Tibetan medicine's syndrome differentiation and treatment. Simultaneously, the formula is compatible with oral medications used in conjunction with external application, forming a comprehensive therapeutic advantage of "external treatment and internal regulation."
[0019] Of course, any product implementing this invention does not necessarily need to achieve all of the advantages described above at the same time. Attached Figure Description
[0020] To more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings used in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0021] Figure 1 This is a schematic flowchart of the method of the present invention; Figure 2 This is a detailed diagram of the preparation process of the herbal ointment in this invention; Figure 3 This is a flowchart illustrating an embodiment of the present invention; Figure 4 This is a diagram of the ointment application in an embodiment of the present invention; Figure 5 This is a schematic diagram illustrating the application of plastic wrap to the ankle joint as mentioned in an embodiment of the present invention. Figure 6 This is a schematic diagram of applying medicine to the knee joint using plastic wrap, as mentioned in an embodiment of the present invention. Detailed Implementation
[0022] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0023] In the description of this invention, it should be understood that the terms "opening", "upper", "lower", "thickness", "top", "middle", "length", "inner", "around", etc., which indicate orientation or positional relationship, are only for the convenience of describing this invention and simplifying the description, and do not indicate or imply that the components or elements referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as limiting this invention.
[0024] like Figure 1 , Figure 3 As shown: The standardized method of the Tibetan external treatment method for gouty arthritis of the present invention specifically includes the following steps: S1. Diagnosis and Inclusion Based on Tibetan medical theory and the diagnostic criteria for gouty arthritis (called "Zhīhōně" in Tibetan medicine) in the "Clinical Diagnosis and Treatment Guidelines for Common Diseases in Tibetan Medicine", the patient is confirmed to meet the following conditions: Typical symptoms: swelling of the affected joint, reddish-brown color like copper, burning pain, hot and hard sensation, and difficulty in flexing and extending the joint; Tibetan medicine signs: The pulse is short and tight, and the urine shows signs of heat with a burnt horn smell. Exclusion criteria: Patients with coronary heart disease, hypertension, cerebral infarction, abnormal liver and kidney function, diabetes, mental disorders, malignant tumors, pregnant or lactating women, and patients who have used anti-inflammatory drugs or immunosuppressants within the past 4 weeks are excluded.
[0025] like Figure 2 As shown: S2. Ointment preparation Raw material preparation: The Tibetan medicine composition includes Xiuqiong Enbao powder and Kacha medicine powder, wherein the Kacha medicine powder is composed of Bangzijuni powder, sickle-shaped thorn bean, cassia seed, yellow sunflower seed, amber, catechu, and iron bar hammer; the iron bar hammer needs to be processed to reduce toxicity.
[0026] Pulverization: After mixing the components of the cardiotonic powder, pulverize it to 80-120 mesh using a universal pulverizer, sieve it and set it aside. This particle size can balance the drug dissolution efficiency and the spreadability of the ointment, avoiding skin irritation caused by overly coarse particles or dryness of the ointment caused by overly fine particles.
[0027] Preparation of the ointment: Weigh 200-300 parts of Xiuqiong Enbao powder and 150-200 parts of Kacha medicine powder by weight, add barley wine (40%-50% alcohol by volume) to make an ointment for external use; the amount of barley wine added should be 1.0-1.5 times the total mass of Kacha medicine powder, and stir until the consistency of the ointment is 800-1000 cP (measured by a rotational viscometer at 25℃), ensuring that the ointment can be applied evenly without dripping.
[0028] Adjustments based on syndrome differentiation: Adjust the proportions of the powder components according to the severity of the patient's symptoms: If the joint swelling score is ≥4 points (0, 2, 4, and 6 points for none, mild, moderate, and severe), increase the weight of the sickle-shaped pea to 40-45 parts to enhance the swelling-reducing effect; if the joint pain score is ≥4 points, increase the weight of the iron bar to 20-25 parts to improve the analgesic effect.
[0029] like Figure 4 , Figure 5 and Figure 6 As shown: S3. Apply to the affected area Pre-treatment before application: Wipe the affected area with Tibetan Five-Flavor Sweet Dew Decoction at 38-42℃ for 5 minutes to dilate skin pores, remove impurities from the skin surface, and promote drug penetration.
[0030] Application procedure: Apply the prepared ointment evenly to the affected joint, ensuring it covers the entire area. The thickness of the ointment is typically 0.3-0.5 cm, and the coverage area extends 1 cm beyond the edge of the affected joint. Then, wrap the ointment with plastic wrap to secure it. The tightness of the wrap should be such that it is airtight and does not impede local blood circulation (provided that the patient does not experience numbness or swelling).
[0031] Application parameters: Apply 1-2 times daily, with each application lasting 45 minutes to 1 hour; if the patient experiences a slight burning sensation during application, the application time can be shortened to 30 minutes per application to avoid skin burns.
[0032] S4. Treatment Course and Assessment Treatment course setting: A treatment course consists of 7 to 14 days. The number of treatment courses can be adjusted according to the patient's efficacy. If the joint pain score decreases by ≥30% after 7 days of treatment, the next course can be started after an interval of 3 days, with a maximum of 2 courses. If there is no significant improvement in efficacy after 7 days of treatment (pain score decreases by <10%), the treatment should be stopped.
[0033] Treatment efficacy assessment: A dual assessment system of "subjective symptoms + objective indicators" is adopted. Subjective symptoms: The improvement of symptoms such as joint pain, swelling, red swelling, burning pain and shiny appearance is assessed through Tibetan medicine syndrome scoring. The efficacy index = [(pre-treatment score - post-treatment score) / pre-treatment score] × 100%, and is divided into significant effect (efficacy index ≥ 70%), effective (30% ≤ efficacy index < 70%), and ineffective (efficacy index < 30%). Objective indicators: Venous blood samples were collected from patients before treatment, on day 7 after treatment, and on day 14 after treatment. Serum inflammatory factor levels, including interleukin-6 (IL-6), procalcitonin (PCT), and high-sensitivity C-reactive protein (hs-CRP), were detected using enzyme-linked immunosorbent assay (ELISA) to assess the effect of inflammation control.
[0034] In an optional embodiment, adjunctive therapy During the application of S3 patches, oral Tibetan medicine can be used as an adjunct therapy, with the choice made based on the patient's constitution and symptoms. If the patient also has kidney essence deficiency (manifested as soreness and weakness of the lower back and knees, and increased urination at night), take Renqing Mangjue Pills orally with warm water; If the patient has meridian obstruction (manifested as difficulty in joint flexion and extension, and fixed pain), administer the Eighteen Flavor Pills orally. If the patient has joint stiffness and limited mobility, administer Twenty-Five Flavor Donkey Blood Powder orally, mixed with warm water.
[0035] A specific application scenario of this invention is as follows: Application Scenario 1: Treatment of patients with common symptoms of gouty arthritis 1. Patient's condition The patient was a 45-year-old male who presented with "redness, swelling, heat and pain in the first metatarsophalangeal joint of the right foot for 3 days". He met the diagnosis of gouty arthritis in Tibetan medicine: his pulse was short and tight, his urine showed signs of heat and had a burnt horn smell; his joint pain score was 4 and his swelling score was 3. He had no other underlying diseases and had not used anti-inflammatory drugs in the past 4 weeks.
[0036] 2. Ointment Preparation Raw material ratio: 250 parts of Xiuqiong Enbao powder, 170 parts of Kacha medicine powder (including 30 parts of Bangzijuni powder, 40 parts of sickle-shaped thorn bean, 20 parts of cassia seed, 20 parts of yellow sunflower seed, 20 parts of amber, 20 parts of catechu, and 20 parts of processed iron rod hammer). Grinding and preparing the ointment: Grind the medicine powder to 100 mesh, add 170 × 1.2 = 204 parts of highland barley wine (45% alcohol by volume), stir until the consistency is 900 cP, and make the ointment.
[0037] 3. Application and Treatment Course Before applying the patch, wipe the metatarsophalangeal joint of the right foot with 39℃ Five Flavors Sweet Dew Decoction, then apply the patch evenly to cover the affected area, fix it with plastic wrap, and apply it twice a day for 45 minutes each time. The treatment course was set for 10 days, without the addition of oral Tibetan medicine.
[0038] 4. Treatment Results Subjective symptoms: After 10 days of treatment, the joint pain score dropped to 1 point, the swelling score dropped to 1 point, the efficacy index was 75%, and it was judged to be significantly effective; Objective indicators: Before treatment, IL-6 was 7.49 pg / ml, PCT was 1.50 ng / mL, and hs-CRP was 13.24 mg / L; after treatment, IL-6 was 3.21 pg / ml, PCT was 0.38 ng / mL, and hs-CRP was 7.82 mg / L. All inflammatory factors were significantly reduced (P < 0.05).
[0039] Application Scenario 2: Treatment of patients with severe gouty arthritis 1. Patient's condition The patient is a 50-year-old female who presented with "redness, swelling and burning pain in the left knee joint for 1 week". Her joint pain score was 6 (severe pain and limited range of motion), and her swelling score was 4. Her pulse was short and tight, and her urine had a burnt horn odor. She had no underlying diseases and had not taken any medication in the past 4 weeks.
[0040] 2. Ointment Preparation Ingredient ratio: 280 parts of Xiuqiong Enbao Powder, 190 parts of Kacha Medicine Powder (including 32 parts of Bangzijuni Powder, 45 parts of Sickle-shaped Oxygen Bean, 22 parts of Cassia Seed, 22 parts of Yellow Sunflower Seed, 22 parts of Amber, 22 parts of Catechu, and 25 parts of Processed Iron Hammer). Due to the pain score being ≥4 points, the amount of Iron Hammer was adjusted to 25 parts. Grinding and preparing the paste: Grind the medicine powder to 80 mesh, add 190 × 1.5 = 285 parts of highland barley wine (50% alcohol by volume), and stir until the consistency is 850 cP.
[0041] 3. Application and adjuvant therapy Before applying the patch, wipe the left knee joint with 40℃ Five-Flavor Sweet Dew Decoction, then evenly apply the patch to cover the affected area. Figure 6 (As shown) Secure with plastic wrap and apply twice daily for 60 minutes each time; Combined oral administration of 18 kinds of frankincense pills; the course of treatment is set at 14 days.
[0042] 4. Treatment Results Subjective symptoms: After 14 days of treatment, the pain score dropped to 2 points, the swelling score dropped to 1 point, the efficacy index was 83%, and it was judged to be significantly effective; Objective indicators: Before treatment, IL-6 was 9.12 pg / ml, PCT was 1.85 ng / mL, and hs-CRP was 15.67 mg / L; after treatment, IL-6 was 3.05 pg / ml, PCT was 0.42 ng / mL, and hs-CRP was 6.93 mg / L, indicating a significant improvement in inflammatory factor levels (P < 0.01).
[0043] Application Scenario 3: Treatment of patients with moderate edematous gouty arthritis 1. Patient's condition The patient was a 42-year-old male who presented with "swelling and burning pain in both ankles for 5 days". His joint swelling score was 4 and his pain score was 3. His pulse was short and tight, and his urine had a burnt horn smell. He also had mild soreness and weakness in his lower back and knees, but no other underlying diseases.
[0044] 2. Ointment Preparation Ingredient ratio: 220 parts Xiuqiong Enbao powder, 160 parts Kacha medicine powder (including 28 parts Bangzijuni powder, 42 parts sickle-shaped yam, 18 parts cassia seed, 18 parts yellow sunflower seed, 18 parts amber, 18 parts catechu, and 18 parts processed iron rod hammer). Due to the swelling score being ≥4 points, the sickle-shaped yam was adjusted to 42 parts. Grinding and preparing the paste: Grind the medicine powder to 120 mesh, add 160 parts of highland barley wine (40% alcohol by volume) and stir until the consistency is 950 cP.
[0045] 3. Application and adjuvant therapy Before applying the patch, wipe both ankle joints with 42℃ Five-Flavor Sweet Dew Decoction, then apply the patch evenly to cover the affected area (e.g. Figure 5 (As shown), secure with plastic wrap and apply once daily for 60 minutes each time; Combined with oral administration of Renqing Mangjue Pills; the course of treatment is set at 7 days.
[0046] 4. Treatment Results Subjective symptoms: After 7 days of treatment, the swelling score dropped to 1 point, the pain score dropped to 1 point, the efficacy index was 70%, and it was judged to be significantly effective; Objective indicators: Before treatment, IL-6 was 8.05 pg / ml, PCT was 1.62 ng / mL, and hs-CRP was 14.11 mg / L; after treatment, IL-6 was 3.87 pg / ml, PCT was 0.45 ng / mL, and hs-CRP was 8.25 mg / L, and the levels of inflammatory factors were significantly reduced (P < 0.05).
[0047] In the description of this specification, references to terms such as "an embodiment," "example," "specific example," etc., indicate that a specific feature, structure, material, or characteristic described in connection with that embodiment or example is included in at least one embodiment or example of the invention. In this specification, illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples.
[0048] The preferred embodiments of the present invention disclosed above are merely illustrative of the invention. These preferred embodiments do not exhaustively describe all details, nor do they limit the invention to the specific implementations described. Clearly, many modifications and variations can be made based on the content of this specification. This specification selects and specifically describes these embodiments to better explain the principles and practical applications of the invention, thereby enabling those skilled in the art to better understand and utilize the invention. The invention is limited only by the claims and their full scope and equivalents.
Claims
1. A standardized method for the external treatment of gouty arthritis using Tibetan medicine, characterized in that... Includes the following steps: S1. Diagnosis and Inclusion: Based on Tibetan medicine theory, the patient was diagnosed with gouty arthritis; S2. Preparation of ointment: Mix the Tibetan medicine composition containing Xiuqiong Enbao powder and Kacha medicine powder with highland barley wine to prepare an ointment for external use; S3. Application to the affected area: Apply the ointment to the affected joint of the patient and fix it in place. Apply 1-2 times a day. S4. Treatment course and evaluation: A treatment course consists of several days, and the efficacy is evaluated before and after treatment.
2. The standardized method for the external treatment of gouty arthritis using Tibetan medicine, as described in claim 1, is characterized in that... In S1, the Tibetan medicine diagnosis requires that the pulse be short and tight, and the urine show signs of heat and have a burnt horn smell.
3. The standardized method for the Tibetan external treatment of gouty arthritis according to claim 1, characterized in that, In step S2, the alcohol volume fraction of the highland barley wine is 40%–50%, and its addition amount is 1.0–1.5 times the total mass of the card powder; and / or, the card powder is pulverized to 80–120 mesh.
4. The standardized method for the Tibetan external treatment of gouty arthritis according to claim 3, characterized in that, The raw materials and their weight ratios in the Tibetan medicine composition in S2 are as follows: Xiuqiong Enbao Powder: 200-300 doses; Cardiotonic powder: 150-200 parts; The medicated powder is composed of the following components: Bangzijuni powder: 25-35 parts, sickle-shaped thorn bean: 35-45 parts, cassia seed: 15-25 parts, yellow okra seed: 15-25 parts, amber: 15-25 parts, catechu: 15-25 parts, iron bar hammer: 15-25 parts; and the iron bar hammer is a medicinal slice that has been processed to reduce toxicity.
5. A standardized method for the external treatment of gouty arthritis using Tibetan medicine, as described in claim 4, characterized in that... The raw materials and their weight ratios in the Tibetan medicine composition in S2 are as follows: Xiuqiong Enbao Powder: 250 doses; Card-applied powder: 170 portions; The medicated powder is composed of the following components: Bangzijuni powder: 28-32 parts, sickle-shaped oxalis: 38-42 parts, cassia seed: 18-22 parts, yellow sunflower seed: 18-22 parts, amber: 18-22 parts, catechu: 18-22 parts, iron bar hammer: 18-22 parts.
6. A standardized method for the external treatment of gouty arthritis using Tibetan medicine, as described in claim 4 or 5, characterized in that... In S2, the proportions of the powder components are adjusted according to the severity of the patient's symptoms: When the joint swelling score is ≥4 points, the weight of *Oxyphyllum scutellariae* should be increased to 40-45 parts. When the joint pain score is ≥4, the weight of the iron hammer should be increased to 20-25 parts.
7. A standardized method for the external treatment of gouty arthritis using Tibetan medicine, as described in claim 1, characterized in that... In step S3, plastic wrap is used for fixation, the application time is 45 minutes to 1 hour, and the thickness of the ointment is 0.3-0.5 cm.
8. A standardized method for the external treatment of gouty arthritis using Tibetan medicine, as described in claim 1, characterized in that... During the application of S3, oral Tibetan medicine is used as an adjunct therapy, including at least one of Renqing Mangjue Pill, Eighteen Flavor Frankincense Pill, and Twenty-Five Flavor Donkey Blood Powder.
9. A standardized method for the external treatment of gouty arthritis using Tibetan medicine, as described in claim 1, characterized in that... In S4, a treatment course lasts 7 to 14 days; the efficacy is assessed by changes in serum inflammatory factor levels before and after treatment, including interleukin-6, procalcitonin, and high-sensitivity C-reactive protein.